The transcription factor Foxp3 is indispensable for the ability of regulatory T cells (T reg cells) to suppress fatal inflammation. Here we characterized the role of Foxp3 in chromatin remodeling and the regulation of gene expression in actively suppressive T reg cells in an inflammatory setting. Although genome-wide occupancy of regulatory elements in DNA by Foxp3 was similar in resting T reg cells and those activated in vivo, Foxp3-bound enhancer elements in the DNA were poised for repression only in activated T reg cells. Following activation, Foxp3-bound sites showed diminished accessibility of chromatin and selective deposition of histone H3 trimethylated at Lys27 (H3K27me3), which was associated with recruitment of the histone methyltransferase Ezh2 and downregulation of the expression of nearby genes. Thus, Foxp3 poises its targets for repression by facilitating the formation of repressive chromatin in T reg cells upon their activation in response to inflammatory cues. npg
r e s o u r c e Regulatory T cells (T reg cells) inhibit inflammatory responses under physiological conditions, during acute and chronic infection and at mucosal surfaces colonized by commensal microorganisms 1, 2 . The bulk of peripheral T reg cells in a homeostatic setting persist in a resting or naive state characterized by only limited, if any, suppressor activity. After an inflammatory challenge, signaling driven by cytokine receptors and T cell antigen receptors (TCRs) elicits the suppressor activity of T reg cells through the induction of various effectors of suppression. T reg cells isolated from such activating environments may have enhanced suppressive ability and potently curtail disease after adoptive transfer 1, 2 .
Although various mechanisms contribute to T reg cell activity in different biological contexts, expression of the transcription factor Foxp3 is indispensable for the suppressor function of T reg cells 3, 4 . Loss of Foxp3 protein in differentiated T reg cells results in their functional deficiency 5 . That observation suggests that Foxp3 might open a unique set of enhancers of genes encoding molecules responsible for the suppressor function of T reg cells; however, examination of the enhancer and DNA-methylation 'landscapes' of T reg cells isolated ex vivo and their precursors has revealed that Foxp3 binds largely to enhancers that are preestablished in a Foxp3-independent manner 6, 7 . While such studies have shown that other factors have a substantial effect on the enhancer 'landscape' of T reg cells formed before the expression of Foxp3, the role of Foxp3 itself in regulating gene expression in T reg cells remains poorly understood. For example, consensus is lacking on the basic means of Foxp3-mediated control of gene expression, with various reports suggesting roles for Foxp3 as an activator or a repressor or both [8] [9] [10] [11] [12] [13] [14] [15] .
Here we investigated Foxp3-dependent mechanisms of gene regulation in T reg cells during active suppression of inflammatory responses. We explored changes in the chromatin 'landscapes' and gene expression associated with binding of Foxp3 in vivo in an acute inflammatory environment induced by transient depletion of T reg cells through the use of Foxp3 DTR mice (which express the human receptor for diphtheria toxin (DT) under control of the endogenous Foxp3 locus) 16 . While a published study of hybridoma cells transfected to express Foxp3 has indicated that the binding of Foxp3 to biologically relevant targets and their regulation may be dependent on TCRtriggered activation of cells 10 , we found that Foxp3 bound the same set of regulatory elements in both resting T reg cells and actively suppressive T reg cells. In response to inflammatory cues, however, the Foxp3 complex incorporated the polycomb-group histone methyltransferase Ezh2 and directed the deposition of repressive chromatin modifications at Foxp3-bound loci. Our results suggest that Foxp3 acts predominantly as a repressor and mediates a previously unknown mode of chromatin regulation: inflammation-induced repression of poised loci prebound by Foxp3.
RESULTS

Characterization of T reg cells activated in vivo
We explored a role for Foxp3 at a genomic level in T reg cells actively engaged in the suppression of widespread inflammatory responses that they normally control. To induce such generalized inflammation, we transiently depleted mice of T reg cells through the brief administration of DT to Foxp3 DTR mice 16 (Supplementary Fig. 1a ). As described before 16 , CD4 + or CD8 + effector T cells (T eff cells) became highly activated, expanded in number and produced cytokines characteristic of the T H Fig. 1b,c and data not shown). After withdrawal of DT, T reg cell numbers in the mice rebounded by days 7-10, and the inflammatory response subsided 4-5 weeks after the initial administration of DT (data not shown).
1, T H 2 and T H 17 subsets of helper T cells upon transient deprivation of T reg cells (Supplementary
We analyzed the activated T reg cells and T eff cells on day 11. At that time point, large numbers of activated CD4 + T eff cells and CD8 + T eff cells still remained, and T reg cell populations were expanded ( Fig. 1a and Supplementary Fig. 1b,c) . Those T reg cells exhibited an activated phenotype, with higher expression of the activation markers CTLA-4, CD25, ICOS, CXCR3 and GITR than that of resting T reg cells from Foxp3 DTR mice given injection of PBS ( Fig. 1b, Supplementary  Fig. 1d and data not shown). Notably, activated T reg cells had higher (Fig. 1c) . The greater abundance of Foxp3 and activation markers indicated a heightened suppressor function of T reg cells rebounding in the inflammatory environment of DT-treated Foxp3 DTR mice. Indeed, T reg cells isolated (with >99% purity) from DT-treated Foxp3 DTR mice were more potent suppressors of the proliferation of T eff cells in vitro (about five times more potent, on a per-cell basis) than were their counterparts isolated from PBS-treated Foxp3 DTR mice (Fig. 1d) . These results indicated that activated T reg cells isolated from DT-treated Foxp3 DTR mice were actively suppressing autoimmune inflammation.
Figure 2 Characterization of gene expression and the localization of Foxp3 in chromatin in T reg cells activated in vivo. (a) Transcriptional profiling of activated and resting T reg cells, Foxp3 GFPKO cells (GFP + CD4 + T cells from Foxp3 GFPKO/WT mice), T eff cells and naive T cells (T n ) by microarray, presented as genes (rows) with significantly different expression in activated T reg cells versus resting T reg cells or T eff cells, with hierarchical clustering based on Euclidean distance, identifying distinct gene-expression clusters (left margin). Right margin, cell type-specific expression and repression. (b) Principal-component analysis of the transcriptomes (outlined areas) of activated and resting T reg cells, T eff cells, naive T cells and Foxp3
To explore whether the activated state of T reg cells featured a unique transcriptional program, we analyzed gene expression in highly purified activated T reg cells from DT-treated Foxp3 DTR mice and resting T reg cells from PBS-treated Foxp3 DTR mice (Supplementary Table 1 ). We then compared those transcriptional profiles with those of activated and resting conventional Foxp3 − CD4 + T cells isolated from the same mice. To account for Foxp3-dependent gene expression, we also analyzed the transcriptome of precursors of T reg cells from mice expressing a Foxp3-null allele with in-frame insertion of sequence encoding a green fluorescent protein (GFP) reporter (Foxp3 GFPKO mice) 3 . We isolated those GFP + Foxp3 GFPKO cells from heterozygous Foxp3 GFPKO/WT female mice, which remained healthy because of the presence of competent T reg cells expressing the wild-type Foxp3 allele as a result of random inactivation of the X chromosome. Foxp3 GFPKO cells have received all signals required for Foxp3 expression during differentiation but lack Foxp3 protein. Transcriptome analysis revealed many genes expressed differently in activated T eff cells and T reg cells in DT-treated Foxp3 DTR mice than in their resting T reg cell and naive CD4 + T cell counterparts in PBS-treated Foxp3 DTR mice ( Fig. 2a and Supplementary Table 2 ). At the same time, both resting T reg cells and activated T reg cells shared a set of transcriptional features distinct from those of both naive T cells and T eff cells. Comparison of those five cell subsets by principal-component analysis revealed that the transcriptome of activated T reg cells was roughly equidistant from that of resting T reg cells and that of activated T eff cells (Fig. 2b,c) . Thus, the gene-expression program of activated T reg cells had a similar pairwise degree of similarity to the gene-expression program of resting T reg cells and that of T eff cells, while the programs of resting T reg cells and T eff cells were further apart. Therefore, the transcriptome of activated T reg cells had features of both the resting T reg cell state and the T eff cell state. Notably, activated T reg cells in DT-treated Foxp3 DTR mice were representative of T reg cells activated under other inflammatory challenges. In this context, comparison of gene-expression changes in activated T reg cells versus T eff cells (both isolated from DT-treated Foxp3 DTR mice) and tumor-infiltrating T reg cells versus T eff cells (both sorted from established B16 mouse melanoma tumors) revealed a strong correlation ( Supplementary  Fig. 1e ). These results suggested that activated T reg cells in DT-treated Foxp3 DTR mice were not much different from activated T reg cells in other biological settings. Supplementary Fig. 3c ). (e) Difference in the expression of Foxp3-bound genes in resting T reg cells versus naive T cells plotted against that difference in Foxp3 GFPKO cells versus naive T cells, among genes with significantly different expression (q < 0.05; Benjamini-Hochberg correction). (f) Difference in the expression of Foxp3-bound genes in activated T reg cells versus T eff cells plotted against that difference in Foxp3 GFPKO cells versus naive T cells (left) or in T eff cells versus naive T cells (right), among genes with significantly different expression (as in e). Data are from experiments reported above ( Fig. 2) and published work 5 .
npg r e s o u r c e
The finding that activated T reg cells had features of resting T reg cell and T eff cell populations raised the possibility that the greater abundance of Foxp3 in activated T reg cells and cooperation with activation-induced nuclear factors enable the engagement of a unique set of enhancers that control gene expression specific to activated T reg cells 10, 17 . Alternatively, Foxp3 could bind the same elements in resting T reg cells and activated T reg cells but perturb gene expression in the latter because of the recruitment of activationinduced factors to sites prebound by Foxp3 under inflammatory conditions. To assess those possibilities, we analyzed the genomewide DNA-binding sites of Foxp3 in both resting T reg cells and activated T reg cells by chromatin immunoprecipitation combined with high-throughput DNA sequencing (ChIP-Seq) (Supplementary Table 3 ). Comparison of those two T reg cell populations showed that the binding of Foxp3 was qualitatively and quantitatively similar at nearly all the loci identified ( Fig. 2d,e ). When we examined replicates independently and modeled them by a negative binomial distribution 18 , we found no consistent difference in the binding of Foxp3 in resting T reg cells versus activated T reg cells ( Supplementary  Fig. 2a-c) . Thus, genome-wide ChIP-seq analysis revealed that Foxp3 occupied the same sites in the absence of inflammation and under inflammatory conditions.
Foxp3 acts predominantly as a transcriptional repressor
To assess the effect of Foxp3 binding on gene expression, we first examined the aggregate expression shift in Foxp3-bound genes in various cellular contexts. In agreement with published reports 7, 9 , the groups of genes containing Foxp3-binding sites showed enrichment for transcripts both upregulated and downregulated in Foxp3 + resting T reg cells relative to their expression in Foxp3 − naive T cells ( Fig. 3a) . Those results seemed to indicate that Foxp3 may facilitate both activation and repression of its target genes 9 . However, analysis of Foxp3 targets in activated T reg cells and T eff cells suggested that Foxp3 acted predominantly as a negative regulator of transcription (Fig. 3b) . The intensity of the binding of Foxp3, as measured by 'read counts' in ChIP-seq data sets, correlated with decreased transcription, not increased transcription (Supplementary Fig. 3a) . It was possible that the 'preferential' downregulation of Foxp3-bound genes in activated T reg cells relative to their expression in T eff cells was a direct result of Foxp3-mediated repression of corresponding target genes. Alternatively, instead of being repressed in activated T reg cells, Foxp3-bound genes could have been upregulated in T eff cells as a result of a Foxp3-independent process, such as T eff cellspecific expression of transcriptional activators with genome-wide DNA-binding patterns similar to those of Foxp3. To address those questions, we examined enrichment for Foxp3 targets among genes expressed differently in various cell types, including T reg cells with a loxP-flanked Foxp3 allele (Foxp3 fl ) subjected to ablation mediated by Cre recombinase (Fig. 3c) , activated and resting T reg cells, and Foxp3 GFPKO cells (Supplementary Fig. 3b ). In all of those comparisons, the only statistically significant association was with gene repression ( Fig. 3d and Supplementary Fig. 3c ). Repression was greatest for Foxp3-bound distal enhancers located upstream or in the first intron ( Supplementary Fig. 3d ). Analysis of signaling pathways identified ' Akt response genes' (genes induced by expression of constitutively active Akt kinase) as being repressed in a Foxp3-dependent manner ( Supplementary Table 4 ).
Since Foxp3 binds some T reg cell-specific genes, we wanted to understand if their high expression in T reg cells was dependent on Foxp3 or was merely a correlation. Foxp3-bound genes upregulated in resting T reg cells were upregulated in a Foxp3-independent manner in GFP + Foxp3 GFPKO cells and had expression similar to that in npg r e s o u r c e resting T reg cells (Fig. 3e) , which suggested that these genes were targeted by trans-activating factors other than Foxp3. That result was in contrast to results obtained for Foxp3-bound genes downregulated in T reg cells, whose repression was Foxp3 dependent (Fig. 3f) .
Notably, most genes with lower expression in activated T reg cells did not have higher expression in T eff cells or Foxp3 GFPKO T cells than in naive T cells (Fig. 3f) . Thus, the observed lower expression of Foxp3-bound genes in activated T reg cells could not be explained by their upregulation in precursors of T eff cells or T reg cells. These results were consistent with published reports showing that Foxp3 acts as a repressor after transient transfection of a forkhead motifcontaining luciferase reporter into a heterologous cell line and in other settings [19] [20] [21] [22] . Thus, our analysis indicated that in both activated T reg cells and their resting counterparts, Foxp3 acted mainly as a repressor of gene transcription.
Foxp3-bound chromatin is repressed in activated T reg cells
Despite the similar genome-wide occupancy of regulatory sites by Foxp3, it remained possible that the effect of Foxp3 binding was different in activated T reg cells versus resting T reg cells. For example, activation-induced transcription factors could be recruited to Foxp3-prebound sites and might act together with Foxp3 to regulate the chromatin state. To further explore that possibility, we assessed the chromatin state of Foxp3-bound genes in T reg cells in the presence or absence of inflammation. We used genome-wide sequence analysis of DNase I-hypersensitive sites (DNase-seq), which enabled a highly reliable assessment of the accessibility and activity of regulatory elements in DNA 23 . DNase-seq revealed ~85,000 DNase hypersensitive sites (DHSs) with high accessibility in at least one of the cell types ( Supplementary Table 5 ). In agreement with published analysis of the enhancer 'landscape' in resting T reg cells 7 , most of the accessible sites in activated T reg cells were also accessible in T eff cells or naive T cells, with the exception of a small set of activated T reg cell-specific regulatory elements in DNA that did not show enrichment for Foxp3 binding. Also consistent with published findings 7 , Foxp3-bound enhancers were on average moderately more accessible in resting T reg cells than in naive T cells, and this was enhanced in a Foxp3-independent way. npg r e s o u r c e particular interest, as expression of Ezh2, another critical component of PRC2, was significantly upregulated in activated T reg cells (Fig. 5a,b) . Coimmunoprecipitation experiments showed that Ezh2 formed a complex with Foxp3 in activated T reg cells but not in resting T reg cells (Fig. 5c) . Because PRC2 deposits the facultative heterochromatin-associated histone modification H3K27me3 (histone H3 trimethylated at Lys27) 25 and is selectively associated with Foxp3 under inflammatory conditions, we explored the genome-wide distribution of H3K27me3 marks in activated T reg cells, resting T reg cells, T eff cells and naive T cells by ChIP-seq ( Fig. 5d and Supplementary  Table 6 ). We found an overall greater number of sites marked by H3K27me3 in activated T reg cells and T eff cells than in naive T cells ( Fig. 5e and Supplementary Fig. 5a ). In concordance with the chromatin-accessibility patterns revealed by DNase-seq, more than 60% of the activated T reg cell-specific, H3K27me3-marked chromatin was bound by Foxp3 (Fig. 5e,f) ; those loci frequently had multiple Foxp3-binding sites (Supplementary Fig. 5b) . Consistent with its repressive function, deposition of H3K27me3 at Foxp3-bound sites in activated T reg cells correlated with a decrease in gene expression ( Supplementary Fig. 5c) . Notably, the Foxp3-bound sites in activated T reg cells showed specific enrichment for H3K27me3, whereas To assess the effect of Foxp3 on the accessibility of chromatin under inflammatory conditions, we analyzed the changes in the DHS 'landscape' of activated T reg cells and T eff cells. We identified a large number of Foxp3-bound sites that were less accessible to DNase in activated T reg cells than in T eff cells (Fig. 4a) . On average, Foxp3bound sites exhibited less accessibility to DNase (P < 10 −151 (t-test); Fig. 4b and Supplementary Fig. 4a) . Moreover, the most-repressed loci in activated T reg cells showed enrichment for Foxp3 binding (P < 10 −73 (hypergeometric test); Fig. 4c and Supplementary  Fig. 4b) . Consistent with the ability of Foxp3 to repress genes associated with T cell activation, Foxp3-bound loci were more accessible in T eff cells not expressing Foxp3 than in resting naive T cells (Fig. 4b) .
in activated T reg cells versus T eff cells and in T eff cells versus naive T cells. RPKM, reads per kilobase per million mapped reads. (h) Difference in H3K27me3 abundance in activated T reg cells versus T eff cells and in resting T reg cells versus naive T cells (presented as
Notably, the chromatin at Foxp3-bound sites was less accessible in activated T reg cells than resting T reg cells ( Fig. 4b and Supplementary  Fig. 4c ), which suggested that this subset of Foxp3-bound enhancers was repressed only in activated, functionally engaged T reg cells. In support of the proposal of the functional relevance of those differences in hypersensitivity to DNase, genes near Foxp3-bound loci with lower accessibility were significantly downregulated in activated T reg cells relative to their expression in resting T reg cells and T eff cells ( Fig. 4d  and Supplementary Fig. 4d ). The observation that Foxp3-bound loci were less accessible in activated T reg cells than in T eff cells and were less accessible in activated T reg cells than in resting T reg cell populations challenged the possibility that diminished accessibility of chromatin at Foxp3-bound sites in activated T reg cells was due merely to an overall greater accessibility of chromatin in T eff cells. These results supported the proposal of the functional relevance of Foxp3 binding at these loci and suggested that the binding of Foxp3 to a large number of functionally important enhancers in resting T reg cells 'poised' them for repression, such that their chromatin accessibility and transcript abundance decreased after activation of T reg cells in response to TCR signaling and inflammatory cues.
PRC2 represses Foxp3-bound chromatin during inflammation
The decrease in the accessibility of chromatin suggested the recruitment of chromatin modifiers upon activation of T reg cells in the inflammatory environment. As shown by mass spectrometry of Foxp3's partners in a bulk T reg cell population, which contains both resting and activated T reg cells, Foxp3 forms large protein complexes that include Suz12, an essential component of PRC2 ('polycomb repressive complex 2') 24 . The role of PRC2 in activated T reg cells was of npg r e s o u r c e loci marked with H3K27me3 specifically in T eff cells did not show enrichment for Foxp3 (Fig. 5g) . Those observations challenged the possibility that decondensation of chromatin by transcriptional activators present in T eff cells accounted for the activated T reg cell-specific enrichment for H3K27me3 observed. In contrast to the widespread increase in H3K27me3 at Foxp3-bound sites observed under inflammatory conditions, Pde3b was the only Foxp3-bound gene that showed significant enrichment for H3K27me3 modifications in resting T reg cells ( Fig. 5h and Supplementary Fig. 5d,e) .
Given the correlation between the binding of Foxp3 and the activated T reg cell-specific deposition of H3K27me3, we considered the possibility that Foxp3 might be required for the recruitment of PRC2. We investigated whether deposition of H3K27me3 was dependent on Foxp3 by ChIP-seq analysis of H3K27me3 in resting and activated Foxp3 GFPKO cells lacking Foxp3, isolated from healthy heterozygous Foxp3 GFPKO/WT female mice and hemizygous Foxp3 GFPKO male mice suffering from immune system-mediated inflammatory syndrome ( Fig. 6a and Supplementary Fig. 6a ). Resting Foxp3 GFPKO cells and resting T reg cells exhibited a similar H3K27me3 'landscape' , except for enrichment for H3K27me3 at the Pde3b locus in resting T reg cells relative to its deposition in Foxp3 GFPKO cells ( Supplementary  Fig. 6b,c) ; this indicated its dependence on Foxp3. Activated Foxp3 GFPKO cells shared with T eff cells and activated T reg cells the inflammation-associated deposition of H3K27me3 at sites not bound by Foxp3 (Supplementary Fig. 6d) . In contrast, at Foxp3-bound sites, Foxp3 was required for the deposition of H3K27me3 in activated T reg cells, as demonstrated by the paucity of such marks at the corresponding sites in activated Foxp3 GFPKO cells or T eff cells lacking Foxp3 (Fig. 6b) . By quantitative assessment, we found that >75% of the Foxp3binding loci were equally repressed in activated T reg cells when compared to Foxp3 GFPKO cells, as in activated T reg cells when compared to T eff cells (Fig. 6c) . Thus, polycomb-mediated silencing of those sites was completely dependent on Foxp3. The remaining ~25% of loci identified as repressed in activated T reg cells compared to T eff cells were partially Foxp3 dependent but were also marginally repressed in a Foxp3-independent way in Foxp3 GFPKO cells (Fig. 6c) . Notably, binding of Foxp3 was not associated with the demethylation of H3K27, since all decreases in H3K27me3 in the T reg cell lineage also occurred in Foxp3 GFPKO cells ( Fig. 6d and Supplementary Fig. 6e) . That finding further supported the proposal of roles for Foxp3 as a repressor and as a chief determinant of the deposition of H3K27me3 in activated T reg cells.
DISCUSSION
We have analyzed Foxp3-mediated regulation of gene expression and the chromatin state in activated T reg cells engaged in the suppression of inflammatory responses. The key distinguishing feature of our study is that we compared activated polyclonal T eff cell and T reg cell populations exposed to signaling via the TCR and cytokines in vivo, in contrast to published analyses of resting T reg cells and naive CD4 + T cells. Those studies were confounded by the potential selective effect of such signaling pathways on the chromatin 'landscape' and the transcriptional output of resting T reg cells compared with that of naive T cells 6, 7, 26 . We found that Foxp3 acted predominantly as a transcriptional repressor and was required for establishment of H3K27me3-marked repressive chromatin in activated T reg cells.
Because PRC2 is the only complex that can mediate de novo trimethylation of H3K27 (ref. 27) , the inflammation-induced deposition of this mark at enhancers bound by Foxp3 suggested a history of PRC2 activity at these sites. Furthermore, a physical interaction between Foxp3 protein and the PRC2 methyltransferase Ezh2 was induced specifically in activated T reg cells, supporting the notion that under inflammatory conditions Foxp3 recruits PRC2. It is possible that the increased expression of Foxp3 and Ezh2 under inflammatory conditions is sufficient to drive their interaction in activated T reg cells. Alternatively, activation-induced post-translational modifications of Foxp3 or Ezh2 or other PRC2 components could serve a role in the recruitment of PRC2. For example, Ezh2 can be phosphorylated at multiple residues by a variety of kinases activated under inflammatory conditions, including Akt, the mitogen-activated protein kinase p38 and the cyclin-dependent kinases Cdk1 and Cdk2. Such modifications control the interactions of Ezh2 with other components of PRC2, transcription factors and noncoding RNA and regulate the recruitment of Ezh2 to specific target genes [28] [29] [30] [31] [32] [33] . These putative mechanisms could also affect the specificity with which EZH2 is targeted to genes and might help explain the finding that only a subset of Foxp3-bound sites are subject to inflammation-induced repression.
The biological role of the cooperative Foxp3-and PRC2-mediated repression of genes remains unknown, because its elucidation would require selective disruption of Foxp3-PRC2 interactions in activated T reg cells. Genetic ablation or knockdown of Ezh2 in T reg cells would seem an inadequate approach, as loss of Ezh2 would affect many genes and result in substantial impairment of cellular function. In CD4 + T cells, Ezh2 deficiency results in impaired activation-induced proliferation 34 and aberrant T H 1 and T H 2 differentiation 35 . Accordingly, chimeric mice in which all T reg cells lack Ezh2 develop fatal inflammation associated with massive T cell activation and cytokine production (S. Hemmers, Y.F., A.A. and A.Y.R., unpublished data). However, it is unclear whether the observed loss of fitness and suppressor function by Ezh2-deficient T reg cells was due to the requirement of Ezh2 for Foxp3dependent or Foxp3-independent regulation of gene expression.
Many of the genes with enhancers repressed by Foxp3 in activated T reg cells encode components of signaling cascades that operate in T eff cells. Downregulation of those genes may modulate the outcome of signaling via the TCR and cytokine receptors and enable the suppressive ability T reg cells. For example, strong signaling via Akt impedes the generation and function of T reg cells 36, 37 ; under inflammatory conditions, many genes whose expression increased in response to constitutive signaling via Akt were repressed in activated T reg cells in a Foxp3dependent manner. Thus, a chief role of Foxp3 may be to uncouple activation-induced signal-transduction pathways from the T eff cell gene-expression program without interfering with activation-induced proliferation, elaboration of inhibitory molecules or homing ability.
Our finding that Foxp3 bound enhancers 'poised for repression' under inflammatory conditions complements published studies describing enhancers 'poised for activation' in development and in response to environmental cues [38] [39] [40] [41] . Published work has shown that the stimulation of terminally differentiated macrophages with lipopolysaccharide elicits the activation of latent enhancers through the recruitment of stimulus-activated transcription factors, which maintain enhanced sensitivity to subsequent stimulation 42, 43 . Similarly, a subset of enhancers in human embryonic stem cells are poised for activation during differentiation 44, 45 . We have described here dynamic regulation of gene expression whereby enhancer chromatin was inducibly repressed. Such regulation may extend to other factors that bind DNA during cell-lineage development and subsequently interact with polycomb in response to environmental cues. 
METHODS
Methods
ONLINE METHODS
In vivo activation and cell isolation. Mice were bred and housed in the pathogen-free animal facility at Memorial Sloan-Kettering Cancer Center and were used in accordance with institutional guidelines. Foxp3 GFPKO and Foxp3 DTR mice have been described 3, 16 . All cells were sorted from spleens and lymph nodes. Naive T cells (GFP − ) and resting T reg cells (GFP + ) cells were obtained from Foxp3 DTR mice, which express GFP from a knock-in IRES-GFP allele in the Foxp3 3′-UTR. Resting Foxp3 GFPKO cells and activated Foxp3 GFPKO cells were GFP + cells sorted from female Foxp3 GFPKO/WT mice and male Foxp3 GFPKO mice, respectively. Activated T reg cell and T eff cell populations were sorted from mice 10 d after intraperitoneal injection of DT (Sigma) at day 0 and day 1. All cell populations were isolated by positive selection with CD4 Dynabeads (Invitrogen) and then were sorted with a FACSAria II (BD Biosciences).
Gene-expression profiling.
High-purity cell populations were sorted in two consecutive rounds to attain a purity of >99%, RNA was extracted with TRIzol and cDNA libraries were hybridized to Affymetrix MOE 430 2.0 chips. Results from arrays were normalized by the robust multiarray average method, and genes identified as being present in at least one cell population were used in subsequent analyses. Differences in expression were estimated with the Bioconductor limma software package with a q-value cutoff of 0.05 after Benjamini-Hochberg adjustment. Genes were defined as being 'present' if they had expression above the threshold in any cell population.
Processing of raw sequencing data. 'Reads' were aligned to the mm9 assembly of the mouse genome (University of California at Santa Cruz) through the use of Bowtie software, with allowance for two mismatches in a 36-nucleotide 'seed' region, and uniquely aligning 'reads' were analyzed. For the removal of monoclonal 'reads' from ChIP analyses, 'reads' with identical starting position were compressed to single 'reads' .
Genome-wide profiling of chromatin accessibility. Chromatin accessibility in cells was assayed by DNase-seq as described 7, 23 . Peaks were 'called' with the HotSpot algorithm, and the 'union' (overlapping set) of the top 100,000 peaks for each cell type was obtained. DNase-sensitive sites with an RPM value of at least 0.5 in the cell in which it was most accessible were analyzed; this resulted in ~87,000 peaks.
Differences in accessibility to DNase were assessed by both quantitative approaches and qualitative approaches, similar to the strategy for analysis of the association of Foxp3 binding with repressed genes. For quantitative analysis, the change in accessibility of Foxp3-bound DHSs relative to that of genome-wide DHSs was assessed by the Kolmogorov-Smirnov test and t-tests (Fig. 4c,d) . Since Foxp3 tends to bind only to chromatin that is moderately to highly accessible, it was critical to demonstrate that the change in Foxp3-bound DHSs was uniform across the entire range of absolute chromatin accessibility (Supplementary Fig. 4 ). For analysis of uniform differences, intensity-normalized differences (in log reads per million) were computed and a 'running' average difference is plotted against absolute accessibility estimated by the RPM value of DNase-seq (Supplementary Fig. 4) . We next assessed the enrichment for Foxp3 for loci with qualitative differences in accessible. To identify those loci, we used an intensity-specific variance model to estimate significance of differences in expression at each DHS, as described 46 . The hypergeometric test for overlap was used to determine the significance of overlap.
Genome-wide analysis of Foxp3 binding sites and H3K27me3. ChIP-seq analysis of Foxp3 was done as described 7 . ChIP-seq analysis of H3K27me3 was done with a protocol similar to that use for ChIP of Foxp3. 1 × 10 6 crosslinked cells were lysed, and mono-and polynucleosomes were obtained by partial digestion of chromatin for 1 min at 37 °C with micrococcal nuclease (12,000 units per ml in a volume of 100 µl). Digestion was stopped by the addition of 10 µl 0.5 M EDTA, and digested nuclei were resuspended in 250 µl nuclear lysis buffer with 1% SDS. After sonication, H3K27me3-bound chromatin was precipitated with an H3K27me3-specific antibody (07-449; Upstate). After 'de-crosslinking' , DNA was isolated as described 7 .
Foxp3-binding sites were 'called' with the SPP peak-calling R package 47 and were quantified by the number of 'reads' that aligned to a window of 200 base pairs around peak center after a strand-specific shift of 75 nucleotides. Peaks with high input-control signal (input RPM value, >0.5) and those that did not show enrichment relative to input (P < 0.001; Poisson analysis with a region of 200 base pairs for comparison of ChIP results to input) were excluded from subsequent analysis. Peaks were assigned to genes by proximity to the gene 'body' . Association with gene expression was correlated with peak rank to identify ~1,300 highly binding sites showing functional enrichment among a total of ~2,800 binding sites 7 (Supplementary Fig. 3) . The difference in the expression of Foxp3 targets and that of genes that are not targets of Foxp3 was estimated by a two-sample Kolmogorov-Smirnov test (for cumulative distributions) and hypergeometric overlap with discrete sets of genes with significantly different expression.
For analysis of H3K27me3-binding sites, 'reads' were aggregated into broad peaks through the identification of loci 5 kilobases in length with an RPM value of >12 and a 'read' count significantly higher than that of input (through the use of the same metrics as those used for Foxp3 normalized to size). Peaks were merged if they were within 10 kilobases of each other and had contiguous blocks with an RPM value of >8. This process resulted in ~5,000 peaks that overlapped 4,300 genes that had reproducible results and showed significant enrichment above input (Supplementary Fig. 7) . Subsequent quantitative analysis of those broad H3K27me3 peaks used reads per 1 kilobase per million (RPKM), since peaks were of variable size. The use of lower thresholds for H3K27me3 peaks resulted in peaks that became increasingly correlated with input signal; a subset of control peaks and peaks with cell population-specific deposition of H3K27me3 were confirmed by ChIP followed by quantitative PCR (Supplementary Fig. 7) . The statistical tests used to analyze the significance of enrichment in the overlap of Foxp3 and H3K27me3 were the same as those used for DNase-seq.
Coimmunoprecipitation and immunoblot analysis. A Nuclear Complex
Co-IP kit was used for coimmunoprecipitation, according to manufacturer's instructions (Active Motif). 5 × 10 6 cells were washed with PBS containing phosphatase inhibitors and then were lysed in hypotonic buffer. Nuclei were isolated by centrifugation and were digested with an enzymatic shearing 'cocktail' . Digested nuclear lysates were incubated overnight at 4 °C with polyclonal affinity-purified rabbit antibody to Foxp3 (prepared in-house) 9 . Foxp3-containing immunocomplexes were captured by the addition of protein A-conjugated magnetic beads, then were washed thoroughly and resuspended in Laemmli sample buffer for fractionation by SDS-PAGE followed by immunoblot analysis with antibody to Ezh2 (612666; BD Biosciences), antibody to Foxp3 (FJK-16s; 14-57773-82; eBioscience) and antibody to histone H3 (ab1791; Abcam). 
